Franklin Street Advisors Inc. NC Sells 4,491 Shares of CME Group Inc. $CME
by Scott Moore · The Cerbat GemFranklin Street Advisors Inc. NC lessened its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 3.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 113,310 shares of the financial services provider’s stock after selling 4,491 shares during the quarter. CME Group makes up 1.8% of Franklin Street Advisors Inc. NC’s holdings, making the stock its 18th biggest position. Franklin Street Advisors Inc. NC’s holdings in CME Group were worth $30,615,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Webster Bank N. A. boosted its position in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 60 shares during the period. Highline Wealth Partners LLC increased its holdings in shares of CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 43 shares during the period. Sagard Holdings Management Inc. acquired a new position in CME Group in the 2nd quarter valued at $30,000. Ransom Advisory Ltd acquired a new position in CME Group in the first quarter valued at about $31,000. Finally, Trifecta Capital Advisors LLC lifted its holdings in shares of CME Group by 59.2% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after acquiring an additional 42 shares during the period. Institutional investors own 87.75% of the company’s stock.
Insiders Place Their Bets
In related news, Director William R. Shepard purchased 262 shares of CME Group stock in a transaction on Thursday, September 25th. The stock was acquired at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the acquisition, the director owned 258,459 shares of the company’s stock, valued at $68,540,742.21. This trade represents a 0.10% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 25,000 shares of CME Group stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the sale, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. This trade represents a 27.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.
CME Group Trading Up 1.2%
CME opened at $269.09 on Friday. CME Group Inc. has a twelve month low of $224.62 and a twelve month high of $290.79. The company has a fifty day moving average of $272.32 and a 200-day moving average of $271.84. The stock has a market cap of $97.03 billion, a PE ratio of 26.07, a price-to-earnings-growth ratio of 3.97 and a beta of 0.28. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The firm had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the company posted $2.68 EPS. The business’s quarterly revenue was down 3.0% on a year-over-year basis. On average, sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be paid a $1.25 dividend. The ex-dividend date of this dividend is Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group’s payout ratio is 48.45%.
Analysts Set New Price Targets
Several brokerages recently weighed in on CME. Keefe, Bruyette & Woods upped their price objective on CME Group from $283.00 to $287.00 and gave the stock a “market perform” rating in a research report on Monday, October 13th. Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a research note on Wednesday, October 8th. Piper Sandler boosted their target price on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Morgan Stanley upped their price target on shares of CME Group from $312.00 to $314.00 and gave the stock an “overweight” rating in a report on Thursday, October 23rd. Finally, Royal Bank Of Canada raised their price objective on CME Group from $282.00 to $295.00 and gave the company a “sector perform” rating in a report on Friday, December 5th. Eight investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $290.47.
View Our Latest Analysis on CME
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
- Five stocks we like better than CME Group
- Golden Cross Stocks: Pattern, Examples and Charts
- Nike Beats on Earnings But Struggles in China and Faces Tariffs
- Stock Market Sectors: What Are They and How Many Are There?
- Is the AI Boom a Bubble? These 2 Dividend Stocks Say No
- High Flyers: 3 Natural Gas Stocks for March 2022
- 4 High-Potential ETFs for 2026: Small Caps, Space Stocks, and More